INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2013
|
Total net assets |
£154.4m |
|
NAV per share |
279.9p |
|
Share price |
227.0p |
|
Total value of unquoted investments |
£25.7m |
|
Total number of portfolio companies |
70 |
|
Cash |
0.5% NAV |
|
Cash committed and reserved to unquoted investments |
(5.2)% NAV |
|
Portfolio companies with < 1 year of cash |
14.06% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Celgene Gilead |
8.3 7.4 6.3 |
|
Onyx |
5.2 |
|
Aptiv |
3.8 |
|
Celldex |
3.2 |
|
Insulet |
3.2 |
|
Alexion |
3.1 |
|
Actelion |
2.6 |
|
Biomarin |
2.5 |
|
|
----------- |
|
Total |
45.6 |
|
Geographical Allocation |
% |
|
United States & Canada |
88 |
|
Europe |
10 |
|
Australia |
1 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
83 |
|
Unquoted |
16 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 APRIL 2013